Tetraneuron
PrivateLast Round
VC Round
Dec 9, 2025
Total Funding Raised
$5.31M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Tetraneuron operates in Healthcare & Life Sciences and is based in Madrid. Its latest recorded funding round was a VC Round in December 2025.
Tetraneuron is a biotechnology company that develops AAV-based gene therapies to treat Alzheimer's disease and other neurodegenerative disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tetraneuron Comparables
Compare Tetraneuron with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LEXEO Therapeutics | 77% | |
| VectorY Therapeutics | 74% | |
| AviadoBio | 74% |
For institutional investors. Book with your work email.
Tetraneuron Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 9, 2025 | ||||
| Seed | Dec 27, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Tetraneuron Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GIMIC Ventures | VC Round |
| Johnson & Johnson Innovation - JLABS | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 162% MoM, reaching 3.4K.
- Aug 16, 2026
Grew 25% QoQ, from 16 to 20 employees.
For institutional investors. Book with your work email.
Tetraneuron Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Tetraneuron's valuation, stock price, and market status.
Is Tetraneuron a public or private company?
Tetraneuron is a private company.
What is the current stock price of Tetraneuron?
Tetraneuron is a private company, so its shares have no public market price. Caplight tracks Tetraneuron's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Tetraneuron worth (valuation)?
Valuation information for Tetraneuron is not publicly available.
Can I buy Tetraneuron stock?
Tetraneuron shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Tetraneuron's last funding round?
Tetraneuron's most recent funding round was VC Round on December 9, 2025.
Who are the main investors in Tetraneuron?
Key investors in Tetraneuron include GIMIC Ventures.
Will Tetraneuron IPO soon?
No public IPO plans have been announced for Tetraneuron.
How can I track Tetraneuron secondary market activity?
Caplight tracks bids, offers, and trades in Tetraneuron's shares on secondary markets.